Panacea Biotec Limited (PANACEABIO.NS)
INR 463.0
(1.47%)
INR 463.0
(1.47%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.19 INR | 96.55% |
| 2022 | -5.51 INR | -103.13% |
| 2021 | 176.05 INR | 830.19% |
| 2020 | -24.11 INR | 23.99% |
| 2019 | -31.72 INR | -614.94% |
| 2018 | 6.16 INR | 149.64% |
| 2017 | -12.41 INR | -17.97% |
| 2016 | -10.52 INR | -251.84% |
| 2015 | -2.99 INR | 82.81% |
| 2014 | -17.39 INR | 5.02% |
| 2013 | -18.31 INR | 52.13% |
| 2012 | -38.25 INR | -13.91% |
| 2011 | -33.58 INR | -246.13% |
| 2010 | 22.98 INR | 87.75% |
| 2009 | 12.24 INR | 223.76% |
| 2008 | -9.89 INR | -150.69% |
| 2007 | 19.51 INR | -18.16% |
| 2006 | 23.84 INR | 149.11% |
| 2005 | 9.57 INR | 144.76% |
| 2004 | 3.91 INR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | -2.58 INR | -1026.09% |
| 2023 FY | - INR | 96.55% |
| 2023 Q1 | 1.78 INR | 185.99% |
| 2023 Q2 | -1.35 INR | -175.84% |
| 2023 Q3 | -0.37 INR | 72.59% |
| 2023 Q4 | -0.23 INR | 37.84% |
| 2022 Q2 | 2.56 INR | 127.92% |
| 2022 Q4 | -2.07 INR | -165.51% |
| 2022 FY | - INR | -103.13% |
| 2022 Q1 | -9.17 INR | -104.54% |
| 2022 Q3 | 3.16 INR | 23.44% |
| 2021 Q4 | 202.03 INR | 2615.94% |
| 2021 FY | - INR | 830.19% |
| 2021 Q3 | -8.03 INR | 7.17% |
| 2021 Q1 | -9.36 INR | -5.76% |
| 2021 Q2 | -8.65 INR | 7.59% |
| 2020 FY | - INR | 23.99% |
| 2020 Q4 | -8.85 INR | -35.32% |
| 2020 Q3 | -6.54 INR | -106.96% |
| 2020 Q2 | -3.16 INR | 43.37% |
| 2020 Q1 | -5.58 INR | 50.97% |
| 2019 Q2 | -12.25 INR | -165.15% |
| 2019 Q3 | -3.48 INR | 71.59% |
| 2019 Q4 | -11.38 INR | -227.01% |
| 2019 FY | - INR | -614.94% |
| 2019 Q1 | -4.62 INR | -115.2% |
| 2018 Q4 | 30.39 INR | 1268.85% |
| 2018 Q2 | -15.83 INR | -175.3% |
| 2018 Q1 | -5.75 INR | 0.0% |
| 2018 FY | - INR | 149.64% |
| 2018 Q3 | -2.60 INR | 83.58% |
| 2017 FY | - INR | -17.97% |
| 2016 FY | - INR | -251.84% |
| 2015 FY | - INR | 82.81% |
| 2014 FY | - INR | 5.02% |
| 2013 FY | - INR | 52.13% |
| 2012 FY | - INR | -13.91% |
| 2011 FY | - INR | -246.13% |
| 2010 FY | - INR | 87.75% |
| 2009 FY | - INR | 223.76% |
| 2008 FY | - INR | -150.69% |
| 2007 FY | - INR | -18.16% |
| 2006 FY | - INR | 149.11% |
| 2005 FY | - INR | 144.76% |
| 2004 FY | - INR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Biocon Limited | 8.55 INR | 102.222% |
| Blue Jet Healthcare Limited | 9.44 INR | 102.013% |
| Concord Biotech Limited | 29.45 INR | 100.645% |
| Dishman Carbogen Amcis Limited | -9.79 INR | 98.059% |
| Jubilant Ingrevia Limited | 11.56 INR | 101.644% |
| Lyka Labs Limited | -0.75 INR | 74.667% |
| Piramal Pharma Limited | 0.14 INR | 235.714% |
| SMS Lifesciences India Limited | 30.08 INR | 100.632% |
| Supriya Lifescience Limited | 14.80 INR | 101.284% |
| Syngene International Limited | 12.71 INR | 101.495% |
| TAKE Solutions Limited | -8.18 INR | 97.677% |
| Zota Health Care Limited | -5.55 INR | 96.577% |